Heartburn Drugs Linked to Risk of First Time Stroke

Comments (0)

Millions of Americans have a problem with heartburn and acid reflux. One of the most common types of medications to treat heartburn and acid reflux is a proton pump inhibitor. Proton pump inhibitors, such as Nexium, Prilosec, and Prevacid, are available over the counter and are very effective in managing heartburn and acid reflux. It’s estimated that about 15 million Americans use proton pump inhibitors per year.

However, a recent study has shown that proton pump inhibitors are linked with an increased risk of first-time stroke. The study found that proton pump inhibitors increased the risk of ischemic strokes, in addition to kidney disease and dementia. An ischemic stroke is the most common type of stroke, and it occurs as a result of blood clots that form in the blood vessels and block off the flow of blood to the brain.

The study included almost 250,000 patients. Almost half of those had used a proton pump inhibitor. The study found that the patient’s risk of ischemic stroke increased by as much as 94 percent as a result of using PPIs. The risk of developing stroke increased by 33 percent with Prilosec and Prevacid, 50 percent with Nexium, and 70 percent with Protonix.

There are concerns that these drugs are being overused. Doctors advise patients to make lifestyle changes to prevent the discomfort of acid reflux and heartburn, such as losing weight, quitting smoking, and cutting back on certain types of foods.

If you believe that you or a loved one has suffered a stroke as a result of taking a proton pump inhibitor, you should speak with an attorney to see if you have a claim. Call the Houston personal injury attorneys at Kennedy Hodges at 855-947-0707. Our team can help. Call today to learn more or to schedule a free consultation. You can also learn more about our team on Google Plus.

Be the first to comment!

Post a Comment

To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."


Email:* (will not be published)


Notify me of follow-up comments via email.